Hospira to expand operations, create 200 jobs

Wednesday, August 29, 2012 11:20 AM

Hospira, a provider of injectable medicines and infusion technologies, is modernizing and expanding the capabilities of its operations in Nash County of N.C.

The company plans to create 200 additional jobs and make new capital investments for the construction, improvement, upfitting and equipping of existing and new facilities. The capital investment will be at least $85 million over the next three years and could grow to be up to $270 million over the next 10 years. The project was made possible in part by a $645,000 grant from the One North Carolina Fund. The state grant will be based on the company investing $85 million over the first three years of the project.  

Salaries will vary by job function, with new positions including technical, supervisory, production and support roles. The average annual wage for the new jobs will be $51,780, plus benefits. The Nash County average annual wage is $34,112.

"Hospira is proud to be able to bring new jobs to the Rocky Mount community with the support of the state of North Carolina and other community partners," said Marty Nealey, vice president, Rocky Mount operations, Hospira. "Our new facility expansion and technology investments underscore the importance of the Rocky Mount facility in supplying life-saving, lower-cost medicines for our patients, customers and health care providers in the global marketplace.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs